Heptaminol
Names
IUPAC name
(RS )-6-Amino-2-methylheptan-2-ol
Identifiers
CAS Number
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard
100.006.144
EC Number
MeSH
Heptaminol
UNII
InChI=1S/C8H19NO/c1-7(9)5-4-6-8(2,3)10/h7,10H,4-6,9H2,1-3H3
Y Key: LREQLEBVOXIEOM-UHFFFAOYSA-N
Y InChI=1/C8H19NO/c1-7(9)5-4-6-8(2,3)10/h7,10H,4-6,9H2,1-3H3
Key: LREQLEBVOXIEOM-UHFFFAOYAN
Properties
Chemical formula
C 8 H 19 N O
Molar mass
145.246 g·mol−1
Density
0.895 g/mL
Boiling point
250 °C (482 °F; 523 K)
Pharmacology
ATC code
C01DX08 (WHO )
Routes of administration
Oral, intravenous, intramuscular
Pharmacokinetics:
Excretion
Renal
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
Corrosive
GHS labelling:
Pictograms
Signal word
Danger
Hazard statements
H314 , H315 , H319 , H335
Precautionary statements
P260 , P264 , P271 , P280 , P301+P330+P331 , P302+P352 , P303+P361+P353 , P304+P340 , P305+P351+P338 , P310 , P312 , P321 , P332+P313 , P337+P313 , P362 , P363 , P403+P233 , P405 , P501
Flash point
105 °C (221 °F; 378 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Heptaminol is an amino alcohol which is classified as a cardiac stimulant (positive inotropic action). It also increases coronary blood flow along with mild peripheral vasoconstriction. It is sometimes used in the treatment of low blood pressure, particularly orthostatic hypotension as it is a potent positive inotrope (improving cardiac contraction).
Use in doping
Heptaminol is classified by the World Anti-Doping Agency as a doping substance.[ 1] In 2008, the cyclist Dmitriy Fofonov tested positive for heptaminol at the Tour de France.[ 2] In June 2010, the swimmer Frédérick Bousquet tested positive.[ 3] In 2013, the cyclist Sylvain Georges tested positive at the Giro d'Italia.[ 4] In 2014, baseball player Joel Piniero tested positive[ 5] as well as St. Louis Cardinals minor league baseball player Yeison Medina.[ 6]
On March 22, 2019, Cycling South Africa reported that Ricardo Broxham has been sanctioned for an anti-doping rule violation of Articles 2.1 and 2.2 of the UCI Anti-Doping Rules after an in-competition test conducted on 18 August 2018 confirmed the presence of Heptaminol in his sample.
The UCI Anti-Doping Tribunal has imposed a period of ineligibility of 12 months for the violation, applicable as of 22 September 2018 up to and including 22 September 2019 and a disqualification of all results from the 2018 UCI Junior Track Cycling World Championships.[ 7]
See also
References
Stimulants
Adamantanes Adenosine antagonists Alkylamines Ampakines
CX-516
CX-546
CX-614
CX-691
CX-717
IDRA-21
LY-404,187
LY-503,430
Nooglutyl
Org 26576
PEPA
S-18986
Sunifiram
Unifiram
Arylcyclohexylamines Benzazepines
6-Br-APB
SKF-77434
SKF-81297
SKF-82958
Cathinones
3-FMC
3-MMC
3,4-DMMC
4-BMC
4-CMC
4-Methylbuphedrone
4-Methylcathinone
4-MEAP
4-Methylpentedrone
Amfepramone
Benzedrone
Buphedrone
Bupropion
Butylone
Cathinone
Dimethylcathinone
Ethcathinone
Ethylone
Flephedrone
Hexedrone
Isoethcathinone
Mephedrone
Methcathinone
Methedrone
Methylenedioxycathinone
Methylone
Mexedrone
N-Ethylbuphedrone
N-Ethylhexedrone
Pentedrone
Pentylone
Phthalimidopropiophenone
Cholinergics
A-84,543
A-366,833
ABT-202
ABT-418
AR-R17779
Altinicline
Anabasine
Arecoline
Bradanicline
Cotinine
Cytisine
Dianicline
Epibatidine
Epiboxidine
GTS-21
Ispronicline
Nicotine
PHA-543,613
PNU-120,596
PNU-282,987
Pozanicline
Rivanicline
Sazetidine A
SIB-1553A
SSR-180,711
TC-1698
TC-1827
TC-2216
Tebanicline
UB-165
Varenicline
WAY-317,538
Convulsants Eugeroics Oxazolines Phenethylamines Phenylmorpholines
3-Fluorophenmetrazine
Fenbutrazate
Fenmetramide
G-130
Manifaxine
Morazone
Morforex
Oxaflozane
PD-128,907
Phendimetrazine
Phenmetrazine
2-Phenyl-3,6-dimethylmorpholine
Pseudophenmetrazine
Radafaxine
Piperazines
2C-B-BZP
3C-PEP
BZP
CM156
DBL-583
GBR-12783
GBR-12935
GBR-13069
GBR-13098
GBR-13119
JJC8-088
MeOPP
MBZP
oMPP
Vanoxerine
Piperidines
1-Benzyl-4-(2-(diphenylmethoxy)ethyl)piperidine
2-Benzylpiperidine
2-Methyl-3-phenylpiperidine
3,4-Dichloromethylphenidate
4-Benzylpiperidine
4-Fluoromethylphenidate
4-Methylmethylphenidate
Desoxypipradrol
Difemetorex
Diphenylpyraline
Ethylnaphthidate
Ethylphenidate
Methylnaphthidate
Isopropylphenidate
JZ-IV-10
Methylphenidate (Dexmethylphenidate)
Nocaine
Phacetoperane
Pipradrol
Propylphenidate
Serdexmethylphenidate
SCH-5472
Phenethylpyrrolidines
2-Diphenylmethylpyrrolidine
4-Cl-PVP
5-DBFPV
α-PPP
α-PBP
α-PCYP
α-PHiP
α-PHP
α-PHPP
α-PVP
α-PVT
Diphenylprolinol
DMPVP
FPOP
FPVP
MDPPP
MDPBP
MPBP
MPEP
MPHP
MPPP
MOPVP
MOPPP
Indapyrophenidone
MDPV
Naphyrone
PEP
Picilorex
Prolintane
Pyrovalerone
Racetams
Oxiracetam
Phenylpiracetam
Phenylpiracetam hydrazide
Psychedelics
2,5-DMA (DOH)
2C-B
2C-D
2C-G-N
5-MeO-DiPT
5-MeO-MiPT
Ariadne (4C-DOM; BL-3912; Dimoxamine)
ASR-2001 (2CB-5PrO)
DOET
DOM
DON
DOPR
LSD
MTFEM
Tropanes
4-fluorotropacocaine
4'-Fluorococaine
Altropane (IACFT)
Brasofensine
CFT (WIN 35,428)
β-CIT (RTI-55)
Cocaethylene
Cocaine
Dichloropane (RTI-111)
Difluoropine
FE-β-CPPIT
FP-β-CPPIT
Ioflupane (123 I)
Norcocaine
PIT
PTT
RTI-31
RTI-32
RTI-51
RTI-112
RTI-113
RTI-120
RTI-121 (IPCIT)
RTI-126
RTI-150
RTI-177
RTI-229
RTI-336
RTI-354
RTI-371
RTI-386
Salicylmethylecgonine
Tesofensine
Troparil (β-CPT, WIN 35,065-2)
Tropoxane
WF-23
WF-33
Tryptamines
4-HO-αMT
4-Methyl-αET
4-Methyl-αMT
5-Chloro-αMT
5-Fluoro-αMT
5-MeO-αET
5-MeO-αMT
5-MeO-DIPT
6-Fluoro-αMT
7-Methyl-αET
αET
αMT
Others
2-MDP
3,3-Diphenylcyclobutanamine
Amfonelic acid
Amineptine
Amiphenazole
Atipamezole
Atomoxetine
Bemegride
Benzydamine
BTQ
BTS 74,398
Centanafadine
Ciclazindol
Clofenciclan
Cropropamide
Crotetamide
D-161
Desipramine
Diclofensine
Dimethocaine
Efaroxan
Etamivan
Fenisorex
Fenpentadiol
Gamfexine
Gilutensin
GSK1360707F
GYKI-52895
Hexacyclonate
Idazoxan
Indanorex
Indatraline
JNJ-7925476
Lazabemide
Leptacline
Lomevactone
LR-5182
Mazindol
Meclofenoxate
Medifoxamine
Mefexamide
Methamnetamine
Methastyridone
Methiopropamine
Naphthylaminopropane
Nefopam
Nikethamide
Nomifensine
O-2172
Oxaprotiline
PNU-99,194
PRC200-SS
Rasagiline
Rauwolscine
Rubidium chloride
Setazindol
Tametraline
Tandamine
Thiopropamine
Thiothinone
Trazium
UH-232
Yohimbine
ATC code: N06B
Vasodilators used in cardiac diseases (C01D)
Nitrovasodilators Quinolone vasodilatorsOthers
Benziodarone
Carbocromen
Cinepazet
Cloridarol
Dilazep
Efloxate
Etafenone
Gapicomine
Heptaminol
Hexobendine
Imolamine
Levosimendan
Nesiritide
Nicorandil
Oxyfedrine
Pimobendan
Prenylamine
Serelaxin
Trapidil
Vericiguat
# WHO-EM
‡ Withdrawn from market
Clinical trials:
† Phase III
§ Never to phase III